Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 76–90 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1013 Bas-Congo Virus and Heartland Virus Multiplex RNA Detection Qualitative Test This diagnostic test evaluates for the presence of RNA from Bas-Congo virus (BASV) and Heartland virus (HRTV) in patient samples.	Whole Blood, Serum, Plasma, CSF	48 hours (report), 36 hours (phone alert)	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Bas-Congo virus RNA", "Heartland virus RNA"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Suspected Bas-Congo virus infection", "Suspected Heartland virus infection", "Evaluation of tick-borne hemorrhagic fever symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 89581-5 ICD-10: A98.8, B33.8 Clinical summary This diagnostic test evaluates for the presence of RNA from Bas-Congo virus (BASV) and Heartland virus (HRTV) in patient samples.
TEST-387 BCR-ABL Gene Rearrangement PCR Quantitative Test This test quantifies the BCR-ABL1 fusion gene transcript level in a blood or bone marrow sample.	Whole blood (3 mL, EDTA) or bone marrow aspirate	Same day (sample received by 9 AM)	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion gene transcript level", "Minimal Residual Disease (MRD)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "10⁻⁴ – 10⁻⁵ (1 in 10,000–100,000 cells)"}, {"name": "Quantification", "reference_range": "Absolute transcript ratio (IS-calibrated)"}, {"name": "MRD Detection Limit", "reference_range": "0.001%"}] Preparation [] Indications ["Diagnosis of Chronic Myeloid Leukemia (CML)", "Diagnosis of Philadelphia-positive Acute Lymphoblastic Leukemia (Ph+ ALL)", "Monitoring molecular response to tyrosine kinase inhibitor (TKI) therapy", "Detection of Minimal Residual Disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 21644-6, 21645-3 ICD-10: C92.10, C91.00 Clinical summary This test quantifies the BCR-ABL1 fusion gene transcript level in a blood or bone marrow sample.
TEST-388 BCR-ABL Gene Rearrangement Qualitative PCR Test This test detects the presence or absence of the BCR-ABL1 fusion gene transcript, indicative of the Philadelphia chromosome translocation.	Whole Blood (EDTA) or Bone Marrow Aspirate	7–10 Business Days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion gene transcript", "Philadelphia chromosome translocation"] Parameters [] Preparation ["No fasting required", "Sample must be collected in an EDTA tube", "Sample must be transported refrigerated"] Indications ["Suspected Chronic Myeloid Leukemia (CML)", "Suspected Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)", "Initial diagnosis of leukemia"] Measurement technique Confirm with laboratory Codes LOINC: 55990-1 ICD-10: C92.10, C91.00, C92.00 Clinical summary This test detects the presence or absence of the BCR-ABL1 fusion gene transcript, indicative of the Philadelphia chromosome translocation.
TEST-1008 BCR-ABL Major Quantitative Test This test quantifies the BCR-ABL1 fusion transcript to monitor treatment response and detect minimal residual disease in CML patients.	Peripheral blood (preferred) or bone marrow aspirate (hospital collection only)	24–36 hours	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcript level", "Minimal Residual Disease (MRD)"] Parameters [{"name": "Precision & Sensitivity", "reference_range": "International Scale (IS)‑calibrated, MR 4.0 , 99.9% precision"}] Preparation ["No fasting required", "Follow all pre-instructions, including signing the consent document and providing your complete clinical history", "Continue regular diet and medications unless otherwise directed by your physician"] Indications ["Monitoring treatment response in CML", "Detecting minimal residual disease (MRD) in CML"] Measurement technique Confirm with laboratory Codes LOINC: 51568-7 ICD-10: C92.1 Clinical summary This test quantifies the BCR-ABL1 fusion transcript to monitor treatment response and detect minimal residual disease in CML patients.
TEST-1010 BCR-ABL Minor (p190) Quantitative PCR Test This test quantifies the p190 BCR-ABL1 fusion transcript in peripheral blood to monitor minimal residual disease (MRD) in patients with Philadelphia chromosome-positive acute lymph...	Peripheral whole blood (EDTA)	24-36 hours	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["p190 BCR-ABL1 fusion transcript (e1a2)", "Minimal Residual Disease (MRD)"] Parameters [{"name": "p190 BCR-ABL1 fusion transcript", "reference_range": "≤ 0.001% (molecular remission threshold)"}] Preparation ["No fasting is required.", "Avoid strenuous exercise for 12 hours before collection.", "Bring a signed consent form, medical history summary, and list of current medications."] Indications ["Monitoring treatment response in Ph+ ALL", "Detecting early relapse in Ph+ ALL", "Guiding tyrosine kinase inhibitor therapy"] Measurement technique Confirm with laboratory Codes LOINC: 69403-6 ICD-10: C91.00 Clinical summary This test quantifies the p190 BCR-ABL1 fusion transcript in peripheral blood to monitor minimal residual disease (MRD) in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
TEST-391 BCR-ABL Quantitative MRD Monitor Test This test evaluates the quantity of the BCR-ABL1 fusion transcript, a marker for Philadelphia chromosome-positive leukemias, to monitor minimal residual disease (MRD).	Peripheral whole blood (EDTA Lavender Top) or bone marrow aspirate	2–3 working days	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcript", "Minimal Residual Disease (MRD)"] Parameters [{"name": "BCR-ABL1 transcript level", "reference_range": "Reported on the International Scale (IS) as a percentage relative to a standardized baseline. MR3.0 (0.1% IS) or deeper is generally associated with improved outcomes."}] Preparation ["No fasting required", "Completed MRD Requisition Form (Form 22) with prior molecular results and current medication list is mandatory"] Indications ["Monitoring treatment response in CML", "Monitoring treatment response in Ph+ ALL", "Assessing molecular remission depth", "Detecting early molecular relapse", "Guiding therapy adjustments"] Measurement technique Confirm with laboratory Codes LOINC: 93923-2 ICD-10: C92.1, C91.0 Clinical summary This test evaluates the quantity of the BCR-ABL1 fusion transcript, a marker for Philadelphia chromosome-positive leukemias, to monitor minimal residual disease (MRD).
TEST-1826 BCR-ABL Variant Panel (Mbcr-b2a2, b3a2, b2a3) Test This test identifies specific BCR-ABL gene fusion transcripts (b2a2, b3a2, b2a3) in bone marrow or peripheral blood.	Bone Marrow / Peripheral Blood	5–7 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL fusion transcripts (b2a2, b3a2, b2a3)", "Presence of specific breakpoint cluster region variants"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant medications"] Indications ["Diagnosis of CML", "Diagnosis of Ph+ ALL", "Monitoring treatment response in CML/Ph+ ALL", "Risk stratification based on BCR-ABL variant"] Measurement technique Confirm with laboratory Codes LOINC: 33754-4 ICD-10: C92.1 Clinical summary This test identifies specific BCR-ABL gene fusion transcripts (b2a2, b3a2, b2a3) in bone marrow or peripheral blood.
TEST-1030 BCR-ABL1 Gene Load Test This test measures the quantity of the BCR-ABL1 fusion gene transcript in a patient's blood or cultured cells, providing a precise measure of leukemia burden.	Whole Blood (EDTA tube) or Culture Cells	3 Working Days (Written Report). Urgent Phone Alert within 24 hours.	950.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion gene transcript levels", "Minimal Residual Disease (MRD)"] Parameters [{"name": "BCR-ABL1 Gene Load", "reference_range": "Reported as a percentage on the International Scale (IS). Interpretation depends on clinical context and treatment goals (e.g., MR3.0, MR4.0, MR4.5)."}] Preparation ["Sign informed consent document", "Bring complete clinical history confirming Philadelphia chromosome-positive leukemia diagnosis", "Disclose all medications, especially anticoagulants", "Do not stop prescribed medication without consulting your doctor"] Indications ["Diagnosis confirmation of CML or Ph+ ALL", "Monitoring treatment response to tyrosine kinase inhibitors", "Detecting minimal residual disease (MRD)", "Assessing eligibility for treatment-free remission"] Measurement technique Confirm with laboratory Codes LOINC: 18425-7 ICD-10: C92.10, C91.00 Clinical summary This test measures the quantity of the BCR-ABL1 fusion gene transcript in a patient's blood or cultured cells, providing a precise measure of leukemia burden.
TEST-1823 BCR-ABL1 Kinase Domain Mutation Analysis (NGS) Test This test identifies mutations in the BCR-ABL1 gene associated with resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia (CML).	Peripheral blood (preferred) or bone marrow aspirate	14–21 days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 kinase domain mutations", "Variant Allele Fraction (VAF)"] Parameters [] Preparation ["No specific drug washout is needed.", "Peripheral blood should be drawn immediately before the next scheduled TKI dose (if applicable)."] Indications ["Monitoring treatment response in CML patients on TKI therapy", "Identifying resistance mutations to guide TKI selection", "Evaluating patients with suspected TKI resistance"] Measurement technique Confirm with laboratory Codes LOINC: 30504-1 ICD-10: C92.1 Clinical summary This test identifies mutations in the BCR-ABL1 gene associated with resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia (CML).
TEST-1827 BCR-ABL1 Kinase Domain Mutation Analysis Test This test identifies specific mutations in the BCR-ABL1 gene that confer resistance to tyrosine kinase inhibitor therapy in CML patients.	Peripheral blood (whole blood) or Bone marrow aspirate	7–8 business days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 kinase domain mutations", "Resistance to tyrosine kinase inhibitors"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Monitoring CML treatment response", "Guiding selection of next-generation TKIs", "Identifying resistance mechanisms"] Measurement technique Confirm with laboratory Codes LOINC: 92836-6 ICD-10: C92.1 Clinical summary This test identifies specific mutations in the BCR-ABL1 gene that confer resistance to tyrosine kinase inhibitor therapy in CML patients.
TEST-1822 BCR-ABL1 Quantification by Droplet Digital PCR (ddPCR) Test This test measures the absolute quantity of the BCR-ABL1 fusion transcript in peripheral blood using Droplet Digital PCR.	Peripheral Whole Blood (EDTA)	2–3 Working Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcript copy number", "Minimal Residual Disease (MRD) burden"] Parameters [{"name": "BCR-ABL1 transcript level", "reference_range": "Reported as % International Scale (IS)"}] Preparation ["No fasting required", "Continue all prescribed TKI medications"] Indications ["Monitoring CML patients on TKI therapy", "Monitoring Ph+ ALL patients on TKI therapy", "Assessing response to TKI therapy", "Detecting molecular relapse"] Measurement technique Confirm with laboratory Codes LOINC: 69380-8 ICD-10: C92.10, C91.00, Z85.6 Clinical summary This test measures the absolute quantity of the BCR-ABL1 fusion transcript in peripheral blood using Droplet Digital PCR.
TEST-1819 BCR-ABL1 Quantitative (p210, p190, p230) Test This test quantifies BCR-ABL1 fusion transcripts (p210, p190, p230) in peripheral blood to monitor treatment response in CML and Ph+ ALL.	Peripheral blood	3–4 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcripts (p210, p190, p230)", "Minimal Residual Disease (MRD)"] Parameters [{"name": "BCR-ABL1 p210", "reference_range": "Reported as a percentage on the International Scale (IS)"}, {"name": "BCR-ABL1 p190", "reference_range": "Reported as a percentage on the International Scale (IS)"}, {"name": "BCR-ABL1 p230", "reference_range": "Reported as a percentage on the International Scale (IS)"}] Preparation ["No fasting is necessary.", "Inform the phlebotomist of all current medications and any recent fever."] Indications ["Monitoring treatment response in CML", "Monitoring treatment response in Ph+ ALL", "Assessing MRD"] Measurement technique Confirm with laboratory Codes LOINC: 34815-6 ICD-10: C92.1 Clinical summary This test quantifies BCR-ABL1 fusion transcripts (p210, p190, p230) in peripheral blood to monitor treatment response in CML and Ph+ ALL.
TEST-3006 BDNF Gene Sequencing for Congenital Central Hypoventilation Syndrome (CCHS) Genetic Test This test evaluates the BDNF gene for mutations associated with Congenital Central Hypoventilation Syndrome (CCHS).	Whole blood (2–3 mL EDTA), extracted DNA (≥1 µg), or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BDNF gene mutations", "Coding region variants"] Parameters [] Preparation ["No specific fasting required", "Avoid heparin tubes; use only EDTA tubes for blood collection"] Indications ["Suspected Congenital Central Hypoventilation Syndrome (CCHS)", "Family history of CCHS", "Need for precise diagnosis and prognosis"] Measurement technique Confirm with laboratory Codes LOINC: 94258-5 ICD-10: G47.35 Clinical summary This test evaluates the BDNF gene for mutations associated with Congenital Central Hypoventilation Syndrome (CCHS).
TEST-393 Beef (Bovine) Protein Detection Test This test detects and measures bovine serum albumin in blood to provide objective evidence of recent beef consumption.	Peripheral Whole Blood (Serum)	5–7 Working Days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Bovine Serum Albumin (Exposure Marker)"] Parameters [{"name": "Bovine Serum Albumin", "reference_range": null}] Preparation ["Provide a full dietary history for the 48 hours preceding the blood draw", "No fasting required", "Refrain from heavy physical exertion for 2 hours before collection"] Indications ["Dietary compliance verification", "Clinical evaluation of unexplained symptoms", "Personalized nutrition protocols", "Beef-free regimen adherence"] Measurement technique Confirm with laboratory Codes LOINC: 6029-8 ICD-10: Z91.010 Clinical summary This test detects and measures bovine serum albumin in blood to provide objective evidence of recent beef consumption.
TEST-1818 Benign Infantile Epilepsy Gene Panel Test This test identifies pathogenic variants in genes associated with self-limiting neonatal and infantile epilepsies.	Peripheral whole blood (EDTA tube)	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in genes like KCNQ2, KCNQ3, SCN1A", "Copy number variants"] Parameters [] Preparation ["No fasting required", "No change to medication schedule"] Indications ["Diagnosis of self-limiting neonatal and infantile epilepsies", "Recurrence risk counselling", "Guiding antiepileptic drug selection"] Measurement technique Confirm with laboratory Codes LOINC: 101369-5 ICD-10: G40.30 Clinical summary This test identifies pathogenic variants in genes associated with self-limiting neonatal and infantile epilepsies.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories